CytoSorbents Corp.
(NASDAQ : CTSO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 2.38%606.161.0%$765.92m
DHRDanaher Corp. 2.17%315.180.7%$682.23m
ABTAbbott Laboratories 3.49%123.510.8%$640.87m
MDTMedtronic Plc -0.12%122.050.6%$533.36m
ISRGIntuitive Surgical, Inc. 1.37%340.900.8%$387.28m
ALGNAlign Technology, Inc. 2.32%608.086.3%$332.80m
BDXBecton, Dickinson & Co. 2.00%247.591.0%$316.75m
DXCMDexCom, Inc. 1.73%559.557.8%$290.22m
SYKStryker Corp. 1.22%274.161.3%$273.61m
EWEdwards Lifesciences Corp. 0.74%115.850.4%$261.52m
BSXBoston Scientific Corp. 0.94%44.551.0%$258.11m
IDXXIDEXX Laboratories, Inc. 0.75%645.783.8%$245.83m
AAgilent Technologies, Inc. 1.38%157.771.6%$219.32m
BAXBaxter International, Inc. 2.49%81.661.8%$194.56m
INMDInMode Ltd. -0.67%84.200.0%$177.26m

Company Profile

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.